1. Home
  2. LPTX
  3. LPTX News

Latest Leap Therapeutics Inc. (LPTX) News on October 30, 2025

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
LPTX

PR Newswire

21 days ago

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal
LPTX

CoinDesk

24 days ago

Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal

LPTX

Associated Press Finance

24 days ago

BC-Most Active Stocks

Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
LPTX

PR Newswire

24 days ago

Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

LPTX

MT Newswires

4 months ago

Leap Therapeutics' Colorectal Cancer Study Shows Significant Benefits; Workforce Cuts Coming

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives
LPTX

PR Newswire

4 months ago

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

Leap Therapeutics Reports First Quarter 2025 Financial Results
LPTX

PR Newswire

6 months ago

Leap Therapeutics Reports First Quarter 2025 Financial Results

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting
LPTX

PR Newswire

6 months ago

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer
LPTX

PR Newswire

6 months ago

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer
LPTX

Benzinga

7 months ago

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

LPTX

MT Newswires

7 months ago

Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
LPTX

PR Newswire

7 months ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study
LPTX

PR Newswire

7 months ago

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

LPTX

MT Newswires

9 months ago

Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright

LPTX

MT Newswires

9 months ago

Leap Therapeutics Shares Drop After Discontinuing Phase 3 Studies of Gastric Cancer Treatment

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
LPTX

PR Newswire

9 months ago

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
LPTX

PR Newswire

10 months ago

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
LPTX

PR Newswire

a year ago

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

Leap Therapeutics Reports Third Quarter 2024 Financial Results
LPTX

PR Newswire

a year ago

Leap Therapeutics Reports Third Quarter 2024 Financial Results

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients
LPTX

PR Newswire

a year ago

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Leap Therapeutics Reports Second Quarter 2024 Financial Results
LPTX

PR Newswire

a year ago

Leap Therapeutics Reports Second Quarter 2024 Financial Results

Italian energy company targets Britain for fleet of 20 mini-nukes
LPTX

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
LPTX

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
LPTX

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
LPTX

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
LPTX

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
LPTX

Simply Wall St.

a year ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
LPTX

Simply Wall St.

a year ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North
LPTX

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

LPTX

GuruFocus.com

a year ago

Leap Therapeutics Inc (LPTX) Q1 2024 Earnings: Financial Resilience Amidst Clinical Progress

Leap Therapeutics Reports First Quarter 2024 Financial Results
LPTX

PR Newswire

a year ago

Leap Therapeutics Reports First Quarter 2024 Financial Results

Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
LPTX

Clinical Trials Arena

2 years ago

Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated

Leap Therapeutics Announces $40 Million Private Placement
LPTX

PR Newswire

2 years ago

Leap Therapeutics Announces $40 Million Private Placement

Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
LPTX

Zacks

2 years ago

Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
LPTX

PR Newswire

2 years ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

OSS Brings AI Edge Compute Solutions to $5 Billion Motorsport Industry with Andretti Global
LPTX

GlobeNewswire

2 years ago

OSS Brings AI Edge Compute Solutions to $5 Billion Motorsport Industry with Andretti Global

What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?
LPTX

Insider Monkey

2 years ago

What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES 2023 FOURTH QUARTER AND FULL YEAR EARNINGS
LPTX

PR Newswire

2 years ago

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES 2023 FOURTH QUARTER AND FULL YEAR EARNINGS

Reservoir Media to Release Third Quarter Fiscal Year 2024 Results on February 7, 2024
LPTX

GlobeNewswire

2 years ago

Reservoir Media to Release Third Quarter Fiscal Year 2024 Results on February 7, 2024

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model
LPTX

PR Newswire

2 years ago

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript
LPTX

Insider Monkey

2 years ago

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript

Terran Orbital Received the Patriot Award from the Office of the Secretary of Defense
LPTX

Business Wire

2 years ago

Terran Orbital Received the Patriot Award from the Office of the Secretary of Defense

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
LPTX

PR Newswire

2 years ago

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

So-Young Announces Update on Repurchase and Cancellation of Shares
LPTX

PR Newswire

2 years ago

So-Young Announces Update on Repurchase and Cancellation of Shares

Forum Energy Technologies Completes Acquisition of Variperm Energy Services
LPTX

Business Wire

2 years ago

Forum Energy Technologies Completes Acquisition of Variperm Energy Services

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
LPTX

PR Newswire

2 years ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
LPTX

PR Newswire

2 years ago

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

Forum Energy Technologies Receives Approval to Proceed with Variperm Acquisition from Canadian Competition Bureau
LPTX

Business Wire

2 years ago

Forum Energy Technologies Receives Approval to Proceed with Variperm Acquisition from Canadian Competition Bureau

INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA
LPTX

GlobeNewswire

2 years ago

INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA

Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3
LPTX

Business Wire

2 years ago

Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
LPTX

PR Newswire

2 years ago

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%
LPTX

Simply Wall St.

2 years ago

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
LPTX

GlobeNewswire

2 years ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why
LPTX

Zacks

2 years ago

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why

Mexican airline Volaris reaches accord with P&W on GTF motor inspections
LPTX

Reuters

2 years ago

Mexican airline Volaris reaches accord with P&W on GTF motor inspections

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit
LPTX

GlobeNewswire

2 years ago

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
LPTX

GlobeNewswire

2 years ago

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference
LPTX

GlobeNewswire

2 years ago

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
LPTX

PR Newswire

2 years ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

Insider Sell Alert: President Anthony Marino Sells 83,130 Shares of ThredUp Inc (TDUP)
LPTX

GuruFocus.com

2 years ago

Insider Sell Alert: President Anthony Marino Sells 83,130 Shares of ThredUp Inc (TDUP)

Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share
LPTX

GlobeNewswire

2 years ago

Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share

Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023
LPTX

GuruFocus.com

2 years ago

Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023

Leap Therapeutics Reports Third Quarter 2023 Financial Results
LPTX

PR Newswire

2 years ago

Leap Therapeutics Reports Third Quarter 2023 Financial Results

LPTX

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Cooper-Standard Holdings Inc Earnings Call

Cooper-Standard Holdings Inc (CPS) Reports 12% Sales Increase and 176. ...
LPTX

GuruFocus.com

2 years ago

Cooper-Standard Holdings Inc (CPS) Reports 12% Sales Increase and 176. ...

Hippo Reports Third Quarter 2023 Financial Results
LPTX

PR Newswire

2 years ago

Hippo Reports Third Quarter 2023 Financial Results

Lesaka Technologies, Inc.'s (NASDAQ:LSAK) top owners are private equity firms with 37% stake, while 35% is held by individual investors
LPTX

Simply Wall St.

2 years ago

Lesaka Technologies, Inc.'s (NASDAQ:LSAK) top owners are private equity firms with 37% stake, while 35% is held by individual investors

Share on Social Networks: